LAMA2-Related Dystrophies: Clinical Phenotypes, Disease Biomarkers, and Clinical Trial ReadinessAnna Sárközy(University College London), Francesco Muntoni(Great Ormond Street Hospital)Frontiers in Molecular NeuroscienceAugust 5, 202010.3389/fnmol.2020.00123Cited by 109SaveCiteExport RISWatch citationsRelated PapersMyoD-induced reprogramming of human fibroblasts and urinary stem cells in vitro: protocols and their applications|Frontiers in Physiology|2023|9TRAPPC11-related muscular dystrophy with hypoglycosylation of alpha-dystroglycan in skeletal muscle and brain.|Research Square|2020|1